nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—ABCC4—Tioguanine—hematologic cancer	0.216	0.417	CbGbCtD
Oseltamivir—CES1—Irinotecan—hematologic cancer	0.109	0.21	CbGbCtD
Oseltamivir—ABCC4—Mercaptopurine—hematologic cancer	0.0897	0.173	CbGbCtD
Oseltamivir—SLC22A8—Mercaptopurine—hematologic cancer	0.056	0.108	CbGbCtD
Oseltamivir—ABCC4—Methotrexate—hematologic cancer	0.0293	0.0566	CbGbCtD
Oseltamivir—SLC22A8—Methotrexate—hematologic cancer	0.0183	0.0353	CbGbCtD
Oseltamivir—NEU1—blood—hematologic cancer	0.0048	0.118	CbGeAlD
Oseltamivir—NEU1—bone marrow—hematologic cancer	0.00465	0.115	CbGeAlD
Oseltamivir—NEU1—lung—hematologic cancer	0.00421	0.104	CbGeAlD
Oseltamivir—NEU1—testis—hematologic cancer	0.00397	0.098	CbGeAlD
Oseltamivir—CES1—hematopoietic system—hematologic cancer	0.00292	0.0719	CbGeAlD
Oseltamivir—NEU1—lymph node—hematologic cancer	0.00288	0.071	CbGeAlD
Oseltamivir—ABCC4—hematopoietic system—hematologic cancer	0.00196	0.0484	CbGeAlD
Oseltamivir—SLC22A8—hematopoietic system—hematologic cancer	0.00195	0.048	CbGeAlD
Oseltamivir—CES1—blood—hematologic cancer	0.00193	0.0476	CbGeAlD
Oseltamivir—CES1—lung—hematologic cancer	0.00169	0.0417	CbGeAlD
Oseltamivir—CES1—testis—hematologic cancer	0.0016	0.0394	CbGeAlD
Oseltamivir—ABCC4—blood—hematologic cancer	0.0013	0.032	CbGeAlD
Oseltamivir—SLC22A8—blood—hematologic cancer	0.00129	0.0318	CbGeAlD
Oseltamivir—ABCC4—bone marrow—hematologic cancer	0.00126	0.031	CbGeAlD
Oseltamivir—CES1—lymph node—hematologic cancer	0.00116	0.0286	CbGeAlD
Oseltamivir—ABCC4—lung—hematologic cancer	0.00114	0.0281	CbGeAlD
Oseltamivir—ABCC4—testis—hematologic cancer	0.00108	0.0265	CbGeAlD
Oseltamivir—ABCC4—lymph node—hematologic cancer	0.000779	0.0192	CbGeAlD
Oseltamivir—NEU1—Metabolism—NUP98—hematologic cancer	0.000101	0.000737	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000101	0.000734	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—LCK—hematologic cancer	9.92e-05	0.000723	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.85e-05	0.000717	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NCOA3—hematologic cancer	9.82e-05	0.000715	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ADCY7—hematologic cancer	9.82e-05	0.000715	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ARNTL—hematologic cancer	9.82e-05	0.000715	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	9.79e-05	0.000713	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	9.77e-05	0.000711	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NUP214—hematologic cancer	9.75e-05	0.00071	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—ALB—hematologic cancer	9.7e-05	0.000707	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.65e-05	0.000703	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—GATA1—hematologic cancer	9.64e-05	0.000702	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—HSPA5—hematologic cancer	9.59e-05	0.000699	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—MTR—hematologic cancer	9.55e-05	0.000696	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ABCG2—hematologic cancer	9.55e-05	0.000696	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ACP5—hematologic cancer	9.55e-05	0.000696	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CA9—hematologic cancer	9.55e-05	0.000696	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PRKCZ—hematologic cancer	9.46e-05	0.000689	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NCOR2—hematologic cancer	9.43e-05	0.000687	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ENO2—hematologic cancer	9.37e-05	0.000682	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	9.36e-05	0.000682	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GSTM1—hematologic cancer	9.3e-05	0.000678	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—HGF—hematologic cancer	9.3e-05	0.000678	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—hematologic cancer	9.24e-05	0.000673	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	9.18e-05	0.000669	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTT1—hematologic cancer	9.08e-05	0.000662	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—IDH1—hematologic cancer	8.98e-05	0.000654	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	8.95e-05	0.000652	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	8.95e-05	0.000652	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	8.95e-05	0.000652	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	8.95e-05	0.000652	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—SDC1—hematologic cancer	8.88e-05	0.000647	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTO1—hematologic cancer	8.88e-05	0.000647	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—TXN—hematologic cancer	8.88e-05	0.000647	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ABCC3—hematologic cancer	8.88e-05	0.000647	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ANXA2—hematologic cancer	8.82e-05	0.000642	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	8.8e-05	0.000641	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	8.7e-05	0.000634	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SPHK1—hematologic cancer	8.69e-05	0.000633	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL3—hematologic cancer	8.5e-05	0.000619	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.48e-05	0.000618	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.37e-05	0.00061	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PTPN1—hematologic cancer	8.35e-05	0.000609	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—UGT1A1—hematologic cancer	8.35e-05	0.000608	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	8.35e-05	0.000608	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—RASGRP1—hematologic cancer	8.22e-05	0.000599	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—GNA13—hematologic cancer	8.2e-05	0.000597	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SYK—hematologic cancer	8.19e-05	0.000597	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CRABP1—hematologic cancer	8.12e-05	0.000592	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SLC22A1—hematologic cancer	8.12e-05	0.000592	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	8.06e-05	0.000587	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.01e-05	0.000583	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—PDGFB—hematologic cancer	8e-05	0.000583	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ANXA2—hematologic cancer	7.96e-05	0.00058	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP4A—hematologic cancer	7.96e-05	0.00058	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SGK1—hematologic cancer	7.96e-05	0.00058	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALOX5—hematologic cancer	7.91e-05	0.000576	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ITGAX—hematologic cancer	7.82e-05	0.00057	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—JAK3—hematologic cancer	7.82e-05	0.00057	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—CCL2—hematologic cancer	7.76e-05	0.000566	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—F3—hematologic cancer	7.71e-05	0.000561	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CD9—hematologic cancer	7.71e-05	0.000561	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NUP98—hematologic cancer	7.66e-05	0.000558	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SGK1—hematologic cancer	7.63e-05	0.000556	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ANXA2—hematologic cancer	7.63e-05	0.000556	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP4A—hematologic cancer	7.63e-05	0.000556	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NQO1—hematologic cancer	7.55e-05	0.00055	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CD44—hematologic cancer	7.55e-05	0.00055	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SELL—hematologic cancer	7.5e-05	0.000546	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ADCY7—hematologic cancer	7.44e-05	0.000542	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NCOA3—hematologic cancer	7.44e-05	0.000542	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.39e-05	0.000539	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—GRB2—hematologic cancer	7.39e-05	0.000538	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NUP214—hematologic cancer	7.39e-05	0.000538	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PDGFA—hematologic cancer	7.37e-05	0.000537	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.31e-05	0.000533	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL3RA—hematologic cancer	7.31e-05	0.000532	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ABCG2—hematologic cancer	7.24e-05	0.000527	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—MTR—hematologic cancer	7.24e-05	0.000527	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	7.17e-05	0.000522	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYCS—hematologic cancer	7.14e-05	0.00052	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—HSP90AA1—hematologic cancer	7.1e-05	0.000517	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ENO2—hematologic cancer	7.1e-05	0.000517	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	7.08e-05	0.000515	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—TGFB1—hematologic cancer	7.02e-05	0.000512	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTT1—hematologic cancer	6.88e-05	0.000502	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	6.87e-05	0.000501	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.78e-05	0.000494	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—CCL2—hematologic cancer	6.73e-05	0.00049	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—SDC1—hematologic cancer	6.73e-05	0.00049	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—hematologic cancer	6.69e-05	0.000487	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—H3F3B—hematologic cancer	6.68e-05	0.000487	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—FGR—hematologic cancer	6.68e-05	0.000487	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—HGF—hematologic cancer	6.68e-05	0.000486	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—CSF2—hematologic cancer	6.6e-05	0.000481	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	6.47e-05	0.000471	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—MYB—hematologic cancer	6.43e-05	0.000469	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ITGAL—hematologic cancer	6.43e-05	0.000469	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.43e-05	0.000468	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.39e-05	0.000465	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PRKCG—hematologic cancer	6.37e-05	0.000464	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—JAK1—hematologic cancer	6.37e-05	0.000464	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—hematologic cancer	6.37e-05	0.000464	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.35e-05	0.000462	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTP1—hematologic cancer	6.3e-05	0.000459	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCC3—hematologic cancer	6.29e-05	0.000458	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—TGFB1—hematologic cancer	6.14e-05	0.000447	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—RAC2—hematologic cancer	6.11e-05	0.000445	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	6.11e-05	0.000445	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.09e-05	0.000444	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.07e-05	0.000442	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCC3—hematologic cancer	6.03e-05	0.00044	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ABCB1—hematologic cancer	5.96e-05	0.000434	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL2RA—hematologic cancer	5.95e-05	0.000434	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.93e-05	0.000432	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.89e-05	0.000429	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CCL2—hematologic cancer	5.88e-05	0.000429	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—hematologic cancer	5.85e-05	0.000426	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTM1—hematologic cancer	5.79e-05	0.000422	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—NCOR1—hematologic cancer	5.79e-05	0.000422	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.77e-05	0.00042	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	5.76e-05	0.000419	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PDGFB—hematologic cancer	5.74e-05	0.000418	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CD44—hematologic cancer	5.72e-05	0.000417	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NQO1—hematologic cancer	5.72e-05	0.000417	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.6e-05	0.000408	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SH2B3—hematologic cancer	5.54e-05	0.000403	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	5.52e-05	0.000402	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.43e-05	0.000396	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYCS—hematologic cancer	5.41e-05	0.000394	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HSP90AA1—hematologic cancer	5.38e-05	0.000392	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—MAPK14—hematologic cancer	5.35e-05	0.00039	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SPARC—hematologic cancer	5.28e-05	0.000385	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.27e-05	0.000384	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.24e-05	0.000381	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.21e-05	0.000379	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—FN1—hematologic cancer	5.18e-05	0.000377	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.14e-05	0.000374	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.13e-05	0.000374	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—LCK—hematologic cancer	5.12e-05	0.000373	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—MTHFR—hematologic cancer	5.11e-05	0.000373	CbGpPWpGaD
Oseltamivir—Cardiac disorder—Methotrexate—hematologic cancer	5.09e-05	0.000167	CcSEcCtD
Oseltamivir—Fatigue—Triamcinolone—hematologic cancer	5.08e-05	0.000167	CcSEcCtD
Oseltamivir—Rash—Vincristine—hematologic cancer	5.06e-05	0.000167	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.06e-05	0.000368	CbGpPWpGaD
Oseltamivir—Dermatitis—Vincristine—hematologic cancer	5.06e-05	0.000166	CcSEcCtD
Oseltamivir—Pain—Triamcinolone—hematologic cancer	5.04e-05	0.000166	CcSEcCtD
Oseltamivir—Headache—Vincristine—hematologic cancer	5.03e-05	0.000166	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.02e-05	0.000366	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—H3F3A—hematologic cancer	5.01e-05	0.000365	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Doxorubicin—hematologic cancer	5e-05	0.000165	CcSEcCtD
Oseltamivir—Nausea—Carmustine—hematologic cancer	4.99e-05	0.000164	CcSEcCtD
Oseltamivir—Epistaxis—Doxorubicin—hematologic cancer	4.99e-05	0.000164	CcSEcCtD
Oseltamivir—Vomiting—Irinotecan—hematologic cancer	4.97e-05	0.000164	CcSEcCtD
Oseltamivir—Vomiting—Mitoxantrone—hematologic cancer	4.97e-05	0.000164	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—GATA3—hematologic cancer	4.97e-05	0.000362	CbGpPWpGaD
Oseltamivir—Sinusitis—Doxorubicin—hematologic cancer	4.96e-05	0.000163	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—hematologic cancer	4.96e-05	0.000361	CbGpPWpGaD
Oseltamivir—Immune system disorder—Methotrexate—hematologic cancer	4.95e-05	0.000163	CcSEcCtD
Oseltamivir—Nausea—Alitretinoin—hematologic cancer	4.95e-05	0.000163	CcSEcCtD
Oseltamivir—Convulsion—Prednisone—hematologic cancer	4.95e-05	0.000163	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—HSPA5—hematologic cancer	4.94e-05	0.00036	CbGpPWpGaD
Oseltamivir—Visual impairment—Epirubicin—hematologic cancer	4.94e-05	0.000163	CcSEcCtD
Oseltamivir—Mediastinal disorder—Methotrexate—hematologic cancer	4.94e-05	0.000163	CcSEcCtD
Oseltamivir—Rash—Irinotecan—hematologic cancer	4.93e-05	0.000162	CcSEcCtD
Oseltamivir—Rash—Mitoxantrone—hematologic cancer	4.93e-05	0.000162	CcSEcCtD
Oseltamivir—Dermatitis—Irinotecan—hematologic cancer	4.92e-05	0.000162	CcSEcCtD
Oseltamivir—Dermatitis—Mitoxantrone—hematologic cancer	4.92e-05	0.000162	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCG2—hematologic cancer	4.92e-05	0.000358	CbGpPWpGaD
Oseltamivir—Headache—Mitoxantrone—hematologic cancer	4.9e-05	0.000161	CcSEcCtD
Oseltamivir—Headache—Irinotecan—hematologic cancer	4.9e-05	0.000161	CcSEcCtD
Oseltamivir—Nausea—Ifosfamide—hematologic cancer	4.89e-05	0.000161	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PRKCZ—hematologic cancer	4.87e-05	0.000355	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.87e-05	0.00016	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.87e-05	0.00016	CcSEcCtD
Oseltamivir—Arthralgia—Prednisone—hematologic cancer	4.86e-05	0.00016	CcSEcCtD
Oseltamivir—Myalgia—Prednisone—hematologic cancer	4.86e-05	0.00016	CcSEcCtD
Oseltamivir—Feeling abnormal—Triamcinolone—hematologic cancer	4.86e-05	0.00016	CcSEcCtD
Oseltamivir—Diarrhoea—Cisplatin—hematologic cancer	4.85e-05	0.00016	CcSEcCtD
Oseltamivir—Erythema multiforme—Epirubicin—hematologic cancer	4.85e-05	0.00016	CcSEcCtD
Oseltamivir—Anxiety—Prednisone—hematologic cancer	4.84e-05	0.000159	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.84e-05	0.000353	CbGpPWpGaD
Oseltamivir—Vomiting—Gemcitabine—hematologic cancer	4.84e-05	0.000159	CcSEcCtD
Oseltamivir—Insomnia—Dexamethasone—hematologic cancer	4.84e-05	0.000159	CcSEcCtD
Oseltamivir—Insomnia—Betamethasone—hematologic cancer	4.84e-05	0.000159	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.83e-05	0.000159	CcSEcCtD
Oseltamivir—Mental disorder—Methotrexate—hematologic cancer	4.8e-05	0.000158	CcSEcCtD
Oseltamivir—Rash—Gemcitabine—hematologic cancer	4.8e-05	0.000158	CcSEcCtD
Oseltamivir—Dermatitis—Gemcitabine—hematologic cancer	4.8e-05	0.000158	CcSEcCtD
Oseltamivir—Eye disorder—Epirubicin—hematologic cancer	4.79e-05	0.000158	CcSEcCtD
Oseltamivir—Hypersensitivity—Etoposide—hematologic cancer	4.79e-05	0.000158	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GSTP1—hematologic cancer	4.77e-05	0.000348	CbGpPWpGaD
Oseltamivir—Headache—Gemcitabine—hematologic cancer	4.77e-05	0.000157	CcSEcCtD
Oseltamivir—Nausea—Vincristine—hematologic cancer	4.77e-05	0.000157	CcSEcCtD
Oseltamivir—Cardiac disorder—Epirubicin—hematologic cancer	4.76e-05	0.000157	CcSEcCtD
Oseltamivir—Hepatitis—Doxorubicin—hematologic cancer	4.75e-05	0.000156	CcSEcCtD
Oseltamivir—Hypersensitivity—Prednisolone—hematologic cancer	4.72e-05	0.000156	CcSEcCtD
Oseltamivir—Dyspepsia—Dexamethasone—hematologic cancer	4.71e-05	0.000155	CcSEcCtD
Oseltamivir—Dyspepsia—Betamethasone—hematologic cancer	4.71e-05	0.000155	CcSEcCtD
Oseltamivir—Urticaria—Triamcinolone—hematologic cancer	4.68e-05	0.000154	CcSEcCtD
Oseltamivir—Asthenia—Etoposide—hematologic cancer	4.66e-05	0.000154	CcSEcCtD
Oseltamivir—Body temperature increased—Triamcinolone—hematologic cancer	4.66e-05	0.000153	CcSEcCtD
Oseltamivir—Anaphylactic shock—Prednisone—hematologic cancer	4.66e-05	0.000153	CcSEcCtD
Oseltamivir—Nausea—Irinotecan—hematologic cancer	4.64e-05	0.000153	CcSEcCtD
Oseltamivir—Nausea—Mitoxantrone—hematologic cancer	4.64e-05	0.000153	CcSEcCtD
Oseltamivir—Immune system disorder—Epirubicin—hematologic cancer	4.63e-05	0.000153	CcSEcCtD
Oseltamivir—Infection—Prednisone—hematologic cancer	4.63e-05	0.000152	CcSEcCtD
Oseltamivir—Mediastinal disorder—Epirubicin—hematologic cancer	4.62e-05	0.000152	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.62e-05	0.000152	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.62e-05	0.000152	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.62e-05	0.000336	CbGpPWpGaD
Oseltamivir—Back pain—Methotrexate—hematologic cancer	4.61e-05	0.000152	CcSEcCtD
Oseltamivir—Fatigue—Dexamethasone—hematologic cancer	4.61e-05	0.000152	CcSEcCtD
Oseltamivir—Fatigue—Betamethasone—hematologic cancer	4.61e-05	0.000152	CcSEcCtD
Oseltamivir—Arrhythmia—Epirubicin—hematologic cancer	4.58e-05	0.000151	CcSEcCtD
Oseltamivir—Pain—Dexamethasone—hematologic cancer	4.57e-05	0.000151	CcSEcCtD
Oseltamivir—Pain—Betamethasone—hematologic cancer	4.57e-05	0.000151	CcSEcCtD
Oseltamivir—Visual impairment—Doxorubicin—hematologic cancer	4.57e-05	0.000151	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.57e-05	0.000333	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Prednisone—hematologic cancer	4.57e-05	0.00015	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—HDAC2—hematologic cancer	4.54e-05	0.000331	CbGpPWpGaD
Oseltamivir—Skin disorder—Prednisone—hematologic cancer	4.53e-05	0.000149	CcSEcCtD
Oseltamivir—Nausea—Gemcitabine—hematologic cancer	4.52e-05	0.000149	CcSEcCtD
Oseltamivir—NEU2—Metabolism—ABCB1—hematologic cancer	4.52e-05	0.000329	CbGpPWpGaD
Oseltamivir—Vomiting—Cisplatin—hematologic cancer	4.51e-05	0.000149	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.51e-05	0.000328	CbGpPWpGaD
Oseltamivir—Mental disorder—Epirubicin—hematologic cancer	4.49e-05	0.000148	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—ITGA4—hematologic cancer	4.49e-05	0.000327	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CD44—hematologic cancer	4.49e-05	0.000327	CbGpPWpGaD
Oseltamivir—Erythema multiforme—Doxorubicin—hematologic cancer	4.49e-05	0.000148	CcSEcCtD
Oseltamivir—Rash—Cisplatin—hematologic cancer	4.47e-05	0.000147	CcSEcCtD
Oseltamivir—Dermatitis—Cisplatin—hematologic cancer	4.47e-05	0.000147	CcSEcCtD
Oseltamivir—Diarrhoea—Etoposide—hematologic cancer	4.45e-05	0.000146	CcSEcCtD
Oseltamivir—Eye disorder—Doxorubicin—hematologic cancer	4.43e-05	0.000146	CcSEcCtD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	4.43e-05	0.000323	CbGpPWpGaD
Oseltamivir—Anaemia—Methotrexate—hematologic cancer	4.41e-05	0.000145	CcSEcCtD
Oseltamivir—Feeling abnormal—Dexamethasone—hematologic cancer	4.41e-05	0.000145	CcSEcCtD
Oseltamivir—Feeling abnormal—Betamethasone—hematologic cancer	4.41e-05	0.000145	CcSEcCtD
Oseltamivir—Cardiac disorder—Doxorubicin—hematologic cancer	4.4e-05	0.000145	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NCOR1—hematologic cancer	4.39e-05	0.000319	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTM1—hematologic cancer	4.39e-05	0.000319	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.38e-05	0.000319	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL3—hematologic cancer	4.38e-05	0.000319	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Dexamethasone—hematologic cancer	4.37e-05	0.000144	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Betamethasone—hematologic cancer	4.37e-05	0.000144	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—hematologic cancer	4.36e-05	0.000318	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IFNA1—hematologic cancer	4.35e-05	0.000317	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Triamcinolone—hematologic cancer	4.34e-05	0.000143	CcSEcCtD
Oseltamivir—Back pain—Epirubicin—hematologic cancer	4.32e-05	0.000142	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.31e-05	0.000314	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PTPN1—hematologic cancer	4.31e-05	0.000314	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—ALB—hematologic cancer	4.3e-05	0.000313	CbGpPWpGaD
Oseltamivir—Dizziness—Etoposide—hematologic cancer	4.3e-05	0.000142	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PIK3CG—hematologic cancer	4.3e-05	0.000313	CbGpPWpGaD
Oseltamivir—Immune system disorder—Doxorubicin—hematologic cancer	4.29e-05	0.000141	CcSEcCtD
Oseltamivir—Vertigo—Methotrexate—hematologic cancer	4.29e-05	0.000141	CcSEcCtD
Oseltamivir—Mediastinal disorder—Doxorubicin—hematologic cancer	4.28e-05	0.000141	CcSEcCtD
Oseltamivir—Urticaria—Betamethasone—hematologic cancer	4.25e-05	0.00014	CcSEcCtD
Oseltamivir—Urticaria—Dexamethasone—hematologic cancer	4.25e-05	0.00014	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.24e-05	0.00014	CcSEcCtD
Oseltamivir—Dizziness—Prednisolone—hematologic cancer	4.24e-05	0.00014	CcSEcCtD
Oseltamivir—Arrhythmia—Doxorubicin—hematologic cancer	4.24e-05	0.00014	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—RASGRP1—hematologic cancer	4.24e-05	0.000309	CbGpPWpGaD
Oseltamivir—Asthenia—Triamcinolone—hematologic cancer	4.23e-05	0.000139	CcSEcCtD
Oseltamivir—Abdominal pain—Betamethasone—hematologic cancer	4.23e-05	0.000139	CcSEcCtD
Oseltamivir—Body temperature increased—Dexamethasone—hematologic cancer	4.23e-05	0.000139	CcSEcCtD
Oseltamivir—Abdominal pain—Dexamethasone—hematologic cancer	4.23e-05	0.000139	CcSEcCtD
Oseltamivir—Body temperature increased—Betamethasone—hematologic cancer	4.23e-05	0.000139	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—SYK—hematologic cancer	4.22e-05	0.000308	CbGpPWpGaD
Oseltamivir—Nausea—Cisplatin—hematologic cancer	4.21e-05	0.000139	CcSEcCtD
Oseltamivir—Insomnia—Prednisone—hematologic cancer	4.21e-05	0.000139	CcSEcCtD
Oseltamivir—Cough—Methotrexate—hematologic cancer	4.16e-05	0.000137	CcSEcCtD
Oseltamivir—Mental disorder—Doxorubicin—hematologic cancer	4.16e-05	0.000137	CcSEcCtD
Oseltamivir—Convulsion—Methotrexate—hematologic cancer	4.13e-05	0.000136	CcSEcCtD
Oseltamivir—Vomiting—Etoposide—hematologic cancer	4.13e-05	0.000136	CcSEcCtD
Oseltamivir—Anaemia—Epirubicin—hematologic cancer	4.13e-05	0.000136	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3R1—hematologic cancer	4.12e-05	0.0003	CbGpPWpGaD
Oseltamivir—Agitation—Epirubicin—hematologic cancer	4.1e-05	0.000135	CcSEcCtD
Oseltamivir—Dyspepsia—Prednisone—hematologic cancer	4.1e-05	0.000135	CcSEcCtD
Oseltamivir—Rash—Etoposide—hematologic cancer	4.1e-05	0.000135	CcSEcCtD
Oseltamivir—Dermatitis—Etoposide—hematologic cancer	4.09e-05	0.000135	CcSEcCtD
Oseltamivir—Headache—Etoposide—hematologic cancer	4.07e-05	0.000134	CcSEcCtD
Oseltamivir—Myalgia—Methotrexate—hematologic cancer	4.06e-05	0.000134	CcSEcCtD
Oseltamivir—Arthralgia—Methotrexate—hematologic cancer	4.06e-05	0.000134	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—IFNA2—hematologic cancer	4.05e-05	0.000295	CbGpPWpGaD
Oseltamivir—Rash—Prednisolone—hematologic cancer	4.04e-05	0.000133	CcSEcCtD
Oseltamivir—Dermatitis—Prednisolone—hematologic cancer	4.04e-05	0.000133	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.03e-05	0.000133	CcSEcCtD
Oseltamivir—Fatigue—Prednisone—hematologic cancer	4.02e-05	0.000132	CcSEcCtD
Oseltamivir—Headache—Prednisolone—hematologic cancer	4.02e-05	0.000132	CcSEcCtD
Oseltamivir—Vertigo—Epirubicin—hematologic cancer	4.01e-05	0.000132	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—JAK2—hematologic cancer	4e-05	0.000291	CbGpPWpGaD
Oseltamivir—Back pain—Doxorubicin—hematologic cancer	4e-05	0.000132	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CREBBP—hematologic cancer	3.98e-05	0.00029	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—MYC—hematologic cancer	3.98e-05	0.00029	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—ALB—hematologic cancer	3.94e-05	0.000287	CbGpPWpGaD
Oseltamivir—Confusional state—Methotrexate—hematologic cancer	3.93e-05	0.000129	CcSEcCtD
Oseltamivir—Dizziness—Triamcinolone—hematologic cancer	3.9e-05	0.000128	CcSEcCtD
Oseltamivir—Cough—Epirubicin—hematologic cancer	3.9e-05	0.000128	CcSEcCtD
Oseltamivir—Anaphylactic shock—Methotrexate—hematologic cancer	3.89e-05	0.000128	CcSEcCtD
Oseltamivir—NEU2—Metabolism—MTHFR—hematologic cancer	3.88e-05	0.000282	CbGpPWpGaD
Oseltamivir—Convulsion—Epirubicin—hematologic cancer	3.87e-05	0.000127	CcSEcCtD
Oseltamivir—Infection—Methotrexate—hematologic cancer	3.87e-05	0.000127	CcSEcCtD
Oseltamivir—Nausea—Etoposide—hematologic cancer	3.86e-05	0.000127	CcSEcCtD
Oseltamivir—Feeling abnormal—Prednisone—hematologic cancer	3.84e-05	0.000126	CcSEcCtD
Oseltamivir—Asthenia—Dexamethasone—hematologic cancer	3.84e-05	0.000126	CcSEcCtD
Oseltamivir—Asthenia—Betamethasone—hematologic cancer	3.84e-05	0.000126	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.84e-05	0.00028	CbGpPWpGaD
Oseltamivir—Nervous system disorder—Methotrexate—hematologic cancer	3.82e-05	0.000126	CcSEcCtD
Oseltamivir—Anaemia—Doxorubicin—hematologic cancer	3.82e-05	0.000126	CcSEcCtD
Oseltamivir—Thrombocytopenia—Methotrexate—hematologic cancer	3.81e-05	0.000126	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Prednisone—hematologic cancer	3.81e-05	0.000125	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—GRB2—hematologic cancer	3.81e-05	0.000278	CbGpPWpGaD
Oseltamivir—Nausea—Prednisolone—hematologic cancer	3.81e-05	0.000125	CcSEcCtD
Oseltamivir—Myalgia—Epirubicin—hematologic cancer	3.8e-05	0.000125	CcSEcCtD
Oseltamivir—Arthralgia—Epirubicin—hematologic cancer	3.8e-05	0.000125	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PDGFA—hematologic cancer	3.8e-05	0.000277	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—hematologic cancer	3.8e-05	0.000277	CbGpPWpGaD
Oseltamivir—Agitation—Doxorubicin—hematologic cancer	3.8e-05	0.000125	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—TGFB1—hematologic cancer	3.79e-05	0.000276	CbGpPWpGaD
Oseltamivir—Anxiety—Epirubicin—hematologic cancer	3.79e-05	0.000125	CcSEcCtD
Oseltamivir—Skin disorder—Methotrexate—hematologic cancer	3.78e-05	0.000125	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PIK3CD—hematologic cancer	3.78e-05	0.000275	CbGpPWpGaD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.77e-05	0.000124	CcSEcCtD
Oseltamivir—Vomiting—Triamcinolone—hematologic cancer	3.75e-05	0.000123	CcSEcCtD
Oseltamivir—NEU1—Metabolism—ALB—hematologic cancer	3.73e-05	0.000272	CbGpPWpGaD
Oseltamivir—Rash—Triamcinolone—hematologic cancer	3.72e-05	0.000122	CcSEcCtD
Oseltamivir—Dermatitis—Triamcinolone—hematologic cancer	3.71e-05	0.000122	CcSEcCtD
Oseltamivir—Vertigo—Doxorubicin—hematologic cancer	3.71e-05	0.000122	CcSEcCtD
Oseltamivir—Urticaria—Prednisone—hematologic cancer	3.7e-05	0.000122	CcSEcCtD
Oseltamivir—Headache—Triamcinolone—hematologic cancer	3.69e-05	0.000122	CcSEcCtD
Oseltamivir—Abdominal pain—Prednisone—hematologic cancer	3.68e-05	0.000121	CcSEcCtD
Oseltamivir—Body temperature increased—Prednisone—hematologic cancer	3.68e-05	0.000121	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.68e-05	0.000268	CbGpPWpGaD
Oseltamivir—Confusional state—Epirubicin—hematologic cancer	3.67e-05	0.000121	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—ABL1—hematologic cancer	3.66e-05	0.000267	CbGpPWpGaD
Oseltamivir—Diarrhoea—Betamethasone—hematologic cancer	3.66e-05	0.000121	CcSEcCtD
Oseltamivir—Diarrhoea—Dexamethasone—hematologic cancer	3.66e-05	0.000121	CcSEcCtD
Oseltamivir—Anaphylactic shock—Epirubicin—hematologic cancer	3.64e-05	0.00012	CcSEcCtD
Oseltamivir—Infection—Epirubicin—hematologic cancer	3.62e-05	0.000119	CcSEcCtD
Oseltamivir—Cough—Doxorubicin—hematologic cancer	3.6e-05	0.000119	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.6e-05	0.000262	CbGpPWpGaD
Oseltamivir—Convulsion—Doxorubicin—hematologic cancer	3.58e-05	0.000118	CcSEcCtD
Oseltamivir—Nervous system disorder—Epirubicin—hematologic cancer	3.57e-05	0.000118	CcSEcCtD
Oseltamivir—Thrombocytopenia—Epirubicin—hematologic cancer	3.57e-05	0.000117	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PIK3R1—hematologic cancer	3.57e-05	0.00026	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.55e-05	0.000117	CcSEcCtD
Oseltamivir—Skin disorder—Epirubicin—hematologic cancer	3.54e-05	0.000117	CcSEcCtD
Oseltamivir—Dizziness—Betamethasone—hematologic cancer	3.54e-05	0.000116	CcSEcCtD
Oseltamivir—Dizziness—Dexamethasone—hematologic cancer	3.54e-05	0.000116	CcSEcCtD
Oseltamivir—Insomnia—Methotrexate—hematologic cancer	3.52e-05	0.000116	CcSEcCtD
Oseltamivir—Myalgia—Doxorubicin—hematologic cancer	3.52e-05	0.000116	CcSEcCtD
Oseltamivir—Arthralgia—Doxorubicin—hematologic cancer	3.52e-05	0.000116	CcSEcCtD
Oseltamivir—Anxiety—Doxorubicin—hematologic cancer	3.5e-05	0.000115	CcSEcCtD
Oseltamivir—Nausea—Triamcinolone—hematologic cancer	3.5e-05	0.000115	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.49e-05	0.000115	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL2—hematologic cancer	3.49e-05	0.000254	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HGF—hematologic cancer	3.44e-05	0.000251	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Prednisone—hematologic cancer	3.43e-05	0.000113	CcSEcCtD
Oseltamivir—Dyspepsia—Methotrexate—hematologic cancer	3.43e-05	0.000113	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.42e-05	0.000249	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CSF2—hematologic cancer	3.4e-05	0.000248	CbGpPWpGaD
Oseltamivir—Vomiting—Dexamethasone—hematologic cancer	3.4e-05	0.000112	CcSEcCtD
Oseltamivir—Vomiting—Betamethasone—hematologic cancer	3.4e-05	0.000112	CcSEcCtD
Oseltamivir—Confusional state—Doxorubicin—hematologic cancer	3.4e-05	0.000112	CcSEcCtD
Oseltamivir—Rash—Betamethasone—hematologic cancer	3.37e-05	0.000111	CcSEcCtD
Oseltamivir—Rash—Dexamethasone—hematologic cancer	3.37e-05	0.000111	CcSEcCtD
Oseltamivir—Anaphylactic shock—Doxorubicin—hematologic cancer	3.37e-05	0.000111	CcSEcCtD
Oseltamivir—Dermatitis—Betamethasone—hematologic cancer	3.37e-05	0.000111	CcSEcCtD
Oseltamivir—Dermatitis—Dexamethasone—hematologic cancer	3.37e-05	0.000111	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.36e-05	0.000111	CcSEcCtD
Oseltamivir—Fatigue—Methotrexate—hematologic cancer	3.36e-05	0.000111	CcSEcCtD
Oseltamivir—Headache—Dexamethasone—hematologic cancer	3.35e-05	0.00011	CcSEcCtD
Oseltamivir—Headache—Betamethasone—hematologic cancer	3.35e-05	0.00011	CcSEcCtD
Oseltamivir—Infection—Doxorubicin—hematologic cancer	3.35e-05	0.00011	CcSEcCtD
Oseltamivir—Asthenia—Prednisone—hematologic cancer	3.34e-05	0.00011	CcSEcCtD
Oseltamivir—Pain—Methotrexate—hematologic cancer	3.33e-05	0.00011	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.32e-05	0.000109	CcSEcCtD
Oseltamivir—Nervous system disorder—Doxorubicin—hematologic cancer	3.31e-05	0.000109	CcSEcCtD
Oseltamivir—Thrombocytopenia—Doxorubicin—hematologic cancer	3.3e-05	0.000109	CcSEcCtD
Oseltamivir—Insomnia—Epirubicin—hematologic cancer	3.3e-05	0.000109	CcSEcCtD
Oseltamivir—NEU1—Metabolism—PIK3CB—hematologic cancer	3.29e-05	0.00024	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—JAK1—hematologic cancer	3.29e-05	0.000239	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PRKCG—hematologic cancer	3.29e-05	0.000239	CbGpPWpGaD
Oseltamivir—Skin disorder—Doxorubicin—hematologic cancer	3.27e-05	0.000108	CcSEcCtD
Oseltamivir—NEU2—Metabolism—PIK3CG—hematologic cancer	3.26e-05	0.000237	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Methotrexate—hematologic cancer	3.21e-05	0.000106	CcSEcCtD
Oseltamivir—Dyspepsia—Epirubicin—hematologic cancer	3.21e-05	0.000106	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.2e-05	0.000233	CbGpPWpGaD
Oseltamivir—Diarrhoea—Prednisone—hematologic cancer	3.19e-05	0.000105	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Methotrexate—hematologic cancer	3.18e-05	0.000105	CcSEcCtD
Oseltamivir—Nausea—Dexamethasone—hematologic cancer	3.18e-05	0.000105	CcSEcCtD
Oseltamivir—Nausea—Betamethasone—hematologic cancer	3.18e-05	0.000105	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.15e-05	0.000104	CcSEcCtD
Oseltamivir—Fatigue—Epirubicin—hematologic cancer	3.14e-05	0.000103	CcSEcCtD
Oseltamivir—Pain—Epirubicin—hematologic cancer	3.12e-05	0.000103	CcSEcCtD
Oseltamivir—Urticaria—Methotrexate—hematologic cancer	3.09e-05	0.000102	CcSEcCtD
Oseltamivir—Dizziness—Prednisone—hematologic cancer	3.08e-05	0.000101	CcSEcCtD
Oseltamivir—Body temperature increased—Methotrexate—hematologic cancer	3.08e-05	0.000101	CcSEcCtD
Oseltamivir—Abdominal pain—Methotrexate—hematologic cancer	3.08e-05	0.000101	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.07e-05	0.000101	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.07e-05	0.000224	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL2RA—hematologic cancer	3.07e-05	0.000224	CbGpPWpGaD
Oseltamivir—Insomnia—Doxorubicin—hematologic cancer	3.05e-05	0.0001	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SRC—hematologic cancer	3.05e-05	0.000222	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CREBBP—hematologic cancer	3.02e-05	0.00022	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Epirubicin—hematologic cancer	3e-05	9.89e-05	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Epirubicin—hematologic cancer	2.98e-05	9.81e-05	CcSEcCtD
Oseltamivir—Dyspepsia—Doxorubicin—hematologic cancer	2.97e-05	9.77e-05	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—hematologic cancer	2.97e-05	0.000216	CbGpPWpGaD
Oseltamivir—Vomiting—Prednisone—hematologic cancer	2.96e-05	9.75e-05	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PDGFB—hematologic cancer	2.96e-05	0.000216	CbGpPWpGaD
Oseltamivir—Rash—Prednisone—hematologic cancer	2.94e-05	9.67e-05	CcSEcCtD
Oseltamivir—Dermatitis—Prednisone—hematologic cancer	2.93e-05	9.66e-05	CcSEcCtD
Oseltamivir—Headache—Prednisone—hematologic cancer	2.92e-05	9.61e-05	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.91e-05	9.58e-05	CcSEcCtD
Oseltamivir—Fatigue—Doxorubicin—hematologic cancer	2.91e-05	9.57e-05	CcSEcCtD
Oseltamivir—Urticaria—Epirubicin—hematologic cancer	2.89e-05	9.53e-05	CcSEcCtD
Oseltamivir—Pain—Doxorubicin—hematologic cancer	2.88e-05	9.49e-05	CcSEcCtD
Oseltamivir—Body temperature increased—Epirubicin—hematologic cancer	2.88e-05	9.48e-05	CcSEcCtD
Oseltamivir—Abdominal pain—Epirubicin—hematologic cancer	2.88e-05	9.48e-05	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—CDK2—hematologic cancer	2.87e-05	0.000209	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Methotrexate—hematologic cancer	2.87e-05	9.45e-05	CcSEcCtD
Oseltamivir—NEU2—Metabolism—PIK3CD—hematologic cancer	2.86e-05	0.000209	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PTEN—hematologic cancer	2.85e-05	0.000207	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALB—hematologic cancer	2.83e-05	0.000206	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—MAPK3—hematologic cancer	2.81e-05	0.000204	CbGpPWpGaD
Oseltamivir—Asthenia—Methotrexate—hematologic cancer	2.79e-05	9.2e-05	CcSEcCtD
Oseltamivir—Feeling abnormal—Doxorubicin—hematologic cancer	2.78e-05	9.15e-05	CcSEcCtD
Oseltamivir—Nausea—Prednisone—hematologic cancer	2.77e-05	9.11e-05	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Doxorubicin—hematologic cancer	2.76e-05	9.08e-05	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—MAPK14—hematologic cancer	2.76e-05	0.000201	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—hematologic cancer	2.72e-05	0.000198	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—EP300—hematologic cancer	2.71e-05	0.000198	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3R1—hematologic cancer	2.7e-05	0.000197	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Epirubicin—hematologic cancer	2.68e-05	8.84e-05	CcSEcCtD
Oseltamivir—Urticaria—Doxorubicin—hematologic cancer	2.68e-05	8.82e-05	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—FN1—hematologic cancer	2.67e-05	0.000195	CbGpPWpGaD
Oseltamivir—Body temperature increased—Doxorubicin—hematologic cancer	2.67e-05	8.78e-05	CcSEcCtD
Oseltamivir—Abdominal pain—Doxorubicin—hematologic cancer	2.67e-05	8.78e-05	CcSEcCtD
Oseltamivir—Diarrhoea—Methotrexate—hematologic cancer	2.66e-05	8.77e-05	CcSEcCtD
Oseltamivir—Asthenia—Epirubicin—hematologic cancer	2.61e-05	8.61e-05	CcSEcCtD
Oseltamivir—Dizziness—Methotrexate—hematologic cancer	2.57e-05	8.48e-05	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PIK3CG—hematologic cancer	2.56e-05	0.000186	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PTPN11—hematologic cancer	2.51e-05	0.000183	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CB—hematologic cancer	2.5e-05	0.000182	CbGpPWpGaD
Oseltamivir—Diarrhoea—Epirubicin—hematologic cancer	2.49e-05	8.21e-05	CcSEcCtD
Oseltamivir—Hypersensitivity—Doxorubicin—hematologic cancer	2.48e-05	8.18e-05	CcSEcCtD
Oseltamivir—Vomiting—Methotrexate—hematologic cancer	2.48e-05	8.15e-05	CcSEcCtD
Oseltamivir—Rash—Methotrexate—hematologic cancer	2.46e-05	8.08e-05	CcSEcCtD
Oseltamivir—Dermatitis—Methotrexate—hematologic cancer	2.45e-05	8.08e-05	CcSEcCtD
Oseltamivir—Headache—Methotrexate—hematologic cancer	2.44e-05	8.03e-05	CcSEcCtD
Oseltamivir—Asthenia—Doxorubicin—hematologic cancer	2.42e-05	7.97e-05	CcSEcCtD
Oseltamivir—Dizziness—Epirubicin—hematologic cancer	2.41e-05	7.93e-05	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.41e-05	0.000175	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CREBBP—hematologic cancer	2.37e-05	0.000173	CbGpPWpGaD
Oseltamivir—Vomiting—Epirubicin—hematologic cancer	2.32e-05	7.63e-05	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	2.32e-05	0.000169	CbGpPWpGaD
Oseltamivir—Nausea—Methotrexate—hematologic cancer	2.31e-05	7.62e-05	CcSEcCtD
Oseltamivir—Diarrhoea—Doxorubicin—hematologic cancer	2.31e-05	7.6e-05	CcSEcCtD
Oseltamivir—Rash—Epirubicin—hematologic cancer	2.3e-05	7.57e-05	CcSEcCtD
Oseltamivir—Dermatitis—Epirubicin—hematologic cancer	2.3e-05	7.56e-05	CcSEcCtD
Oseltamivir—Headache—Epirubicin—hematologic cancer	2.28e-05	7.52e-05	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.25e-05	0.000164	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CD—hematologic cancer	2.25e-05	0.000164	CbGpPWpGaD
Oseltamivir—Dizziness—Doxorubicin—hematologic cancer	2.23e-05	7.34e-05	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—ALB—hematologic cancer	2.22e-05	0.000162	CbGpPWpGaD
Oseltamivir—Nausea—Epirubicin—hematologic cancer	2.16e-05	7.13e-05	CcSEcCtD
Oseltamivir—NEU2—Metabolism—PTEN—hematologic cancer	2.16e-05	0.000157	CbGpPWpGaD
Oseltamivir—Vomiting—Doxorubicin—hematologic cancer	2.14e-05	7.06e-05	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.14e-05	0.000156	CbGpPWpGaD
Oseltamivir—Rash—Doxorubicin—hematologic cancer	2.13e-05	7e-05	CcSEcCtD
Oseltamivir—Dermatitis—Doxorubicin—hematologic cancer	2.12e-05	6.99e-05	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PIK3R1—hematologic cancer	2.12e-05	0.000155	CbGpPWpGaD
Oseltamivir—Headache—Doxorubicin—hematologic cancer	2.11e-05	6.95e-05	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—JAK2—hematologic cancer	2.06e-05	0.00015	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—EP300—hematologic cancer	2.06e-05	0.00015	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.05e-05	0.000149	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CA—hematologic cancer	2.01e-05	0.000146	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	2e-05	0.000146	CbGpPWpGaD
Oseltamivir—Nausea—Doxorubicin—hematologic cancer	2e-05	6.59e-05	CcSEcCtD
Oseltamivir—ABCC4—Hemostasis—PIK3CB—hematologic cancer	1.96e-05	0.000143	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ALB—hematologic cancer	1.92e-05	0.00014	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	1.89e-05	0.000138	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL2—hematologic cancer	1.8e-05	0.000131	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKT1—hematologic cancer	1.64e-05	0.000119	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—EP300—hematologic cancer	1.61e-05	0.000118	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SRC—hematologic cancer	1.57e-05	0.000114	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—hematologic cancer	1.53e-05	0.000111	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CA—hematologic cancer	1.52e-05	0.000111	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—NRAS—hematologic cancer	1.51e-05	0.00011	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—MAPK3—hematologic cancer	1.45e-05	0.000105	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TGFB1—hematologic cancer	1.4e-05	0.000102	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KRAS—hematologic cancer	1.3e-05	9.47e-05	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKT1—hematologic cancer	1.24e-05	9.05e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CA—hematologic cancer	1.19e-05	8.7e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—hematologic cancer	1.16e-05	8.41e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HRAS—hematologic cancer	1.1e-05	8.05e-05	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT1—hematologic cancer	9.75e-06	7.11e-05	CbGpPWpGaD
